Novel β-secretase cleavage of β-amyloid precursor protein in the endoplasmic reticulum/intermediate compartment of NT2N cells

Journal of Cell Biology

Volumn 138, Issue 3, 1997, Pages 671-680

  Chyung, Abraham S C ^a   Greenberg, Barry D ^b   Cook, David G ^a   Doms, Robert W ^a   Lee, Virginia M Y ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CEPHALON INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BREFELDIN A;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL LYSATE; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING;

AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ASPARTIC ENDOPEPTIDASES; BREFELDIN A; CELL COMPARTMENTATION; CHO CELLS; CRICETINAE; CYCLOPENTANES; ENDOPEPTIDASES; ENDOPLASMIC RETICULUM; GLYCOSYLATION; GOLGI APPARATUS; HUMANS; NEURONS; PEPTIDE FRAGMENTS; PROTEIN PROCESSING, POST-TRANSLATIONAL; TUMOR CELLS, CULTURED;

EID: 0030739716     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.138.3.671     Document Type: Article

References (56)

1. Arai, H., V.M.-Y. Lee, M. Messinger, B.D. Greenberg, D.E. Lowery, and J.Q. Trojanowski. 1991. Expression patterns of β-amyloid precursor protein (βAPP) in neural and nonneural human tissues from Alzheimer's disease and control subjects. Ann. Neurol. 30:686-693.
2. Busciglio, J., D.H. Gabuzda, P. Matsudaira, and B.A. Yankner. 1993. Generation of β-amyloid in the secretory pathway in neuronal and nonneuronal cells. Proc. Natl. Acad. Sci. USA. 90:2092-2096.
3. Cai, X.-D., T.E. Golde, and S.G. Younkin. 1993. Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science (Wash. DC). 259:514-516.
4. Citron, M., T. Oltersdorf, C. Haass, L. McConlogue, A.Y. Hung, P. Seubert, C. Vigo-Peltrey, I. Lieberburg, and D.J. Selkoe. 1992. Mutation of the β-amyloid precursor protein in Alzheimer's disease increases β-protein production. Nature (Lond.). 360:672-674.
5. Cook, D.G., J.C. Sung, T.E. Golde, K.M. Felsenstein, R.E. Wojczyk, R.E. Tanzi, J.Q. Trojanowski, V.M.-Y. Lee, and R.W. Doms. 1996. Expression and analysis of presenilin 1 in a human neuronal system: localization in cell bodies and dendrites. Proc. Natl. Acad. Sci. USA. 93:9223-9228.
6. Cook, D.G., M. Forman, J.C. Sung, S. Leight, D.L. Kolson, T. Iwatsubo, V.M.-Y. Lee, and R. W. Doms. 1997. Alzheimer Aβ (42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells. Nat. Med. In press.
7. Doms, R.W., G. Russ, and J.W. Yewdell. 1989. Brefeldin A redistributes resident and itinerant Golgi proteins to the endoplasmic reticulum. J. Cell Biol. 109:61-72.
8. Esch, F.S., P.S. Keim, E.C. Beattie, R.W. Blacher, A.R. Culwell, T. Oltersdorf, D. McClure, and P.J. Ward. 1990. Cleavage of amyloid β-peptide during constitutive processing of its precursor. Science (Wash. DC). 248:1122-1124.
9. Essalmani, R., A.-F. Macq, L. Mercken, and J.-N. Octave. 1996. Missense mutations associated with familial Alzheimer's disease in Sweden lead to the production of the amyloid peptide without internalization of its precursor. Biochem. Biophy. Res. Commun. 218:89-96.
10. Golde, T.E., S. Estus, M. Usiak, L.H. Younkin, and S.G. Younkin. 1990. Expression of β amyloid protein precursor mRNAs: recognition of a novel alternatively spliced form and quantitation in Alzheimer's disease using PCR. Neuron. 4:253-267.
11. Golde, T.E., S. Estus, L.H. Younkin, D.J. Selkoe, and S.G. Younkin. 1992. Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science (Wash. DC). 255:728-730.
12. Haass, C., E.H. Koo, A. Mellon, A.Y. Hung, and D.J. Selkoe. 1992a. Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature (Lond.). 357:500-503.
13. Haass, C., M.G. Schlossmacher, A.Y. Hung, C. Vigo-Pelfrey, A. Mellon, B.L. Ostaszewski, I. Lieberburg, E.H. Koo, D. Schenk, D.B. Teplow, et al. 1992b. Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature (Lond.). 359:322-325.
14. Haass, C., C.A. Lemere, A. Capell, M. Citron, P. Seubert, D. Schenk, L. Lannfelt, and D.J. Selkoe. 1995a. The Swedish mutation causes early-onset Alzheimer's disease by β-secretase cleavage within the secretory pathway. Nat. Med. 1:1291-1296.
15. Haass, C., E.H. Koo, A. Capell, D.B. Teplow, and D.J. Selkoe. 1995b. Polarized sorting of β-amyloid precursor protein and its proteolytic products in MDCK cells is regulated by two independent signals. J. Cell Biol. 128:537-547.
16. Higaki, J., D. Quon, Z. Zhong, and B. Cordell. 1995. Inhibition of β-amyloid formation identifies proteolytic precursors and subcellular site of catabolism. Neuron. 14:651-659.
17. Howland D.S., M.J. Savage, F.A. Huntress, R.E. Wallace, D.A. Schwartz, T. Loh, R.H. Melloni, Jr. I.J. Degennaro, B.D. Greenberg, R. Simam, et al. 1995. Mutant and native human β-amyloid precursor proteins in transgenic mouse brain. Neurobiol. Aging. 16:685-699.
18. Jackson, M.R., T. Nilsson, and P.A. Peterson. 1990. Identification of a consensus motif for retention of transmembrane proteins in the endoplasmic reticulum. EMBO (Eur. Mol. Biol. Organ.) J. 9:3153-3162.
19. Jackson, M.R., T. Nilsson, and P.A. Peterson. 1993. Retrieval of transmembrane proteins to the endoplasmic reticulum. J. Cell Biol. 121:317-333.
20. Kang, J., and B. Muller-Hill. 1990. Differential splicing of Alzheimer's disease amyloid A4 precursor RNA in rat tissues: PreA4(695) mRNA is predominantly produced in rat and human brain. Biochem. Biophys. Res. Commun. 166:1192-1200.
21. Kang, J., H.-G. Lemaire, A. Unterbeck, M. Alsboum, C.L. Masters, K.H. Grzeschik, G. Multhaup, K. Beyreuther, and B. Müller-Hill. 1987. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature (Lond.). 325:733-736.
22. Kim, K.S., D.L. Miller, V.J. Sapienza, C.-M. Chen, C. Bai, I. Grundke-Iqbal, J.R. Currie, and H.M. Wisniewski. 1988. Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci. Res. Commun. 2:121-130.
23. Kitaguchi, N., Y. Takahashi, Y. Tokushima, S. Shiojiri, and H. Ito. 1988. Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature (Lond.). 331:530-532.
24. Knops J., S. Gandy, P. Greengard, I. Lieberburg, S. Sinhas. 1993. Serine phosphorylation of the secreted extracellular domain of APP. Biochem Biophys. Res. Commun. 197:380-385.
25. Koo, E.H., and S. Squazzo. 1994. Evidence that production and release of amyloid β-protein involves the endocytic pathway. J. Biol. Chem. 269:17386-17389.
26. Kovacs, D.M., H.J. Fausetl, K.J. Page, T.-W. Kim, R.D. Moir, D.E. Merriam, R.D. Hollister, O.G. Hallmark, R. Mancini, K.M. Felsenstein, et al. 1996. Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nat. Med. 2:224-229.
27. Lai, A., S. Sisodia, and I.S. Trowbridge. 1995. Characterization of sorting signals in the β-amyloid precursor protein cytoplasmic domain. J. Biol. Chem. 270:3565-3573.
28. Liljestrom, P., and H. Garoff. 1991. A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Biotechnology (NY). 9:1356-1361.
29. Lippincott-Schwartz, J.L., L.C. Yuan, J.S. Banifacino, and R.D. Klausner. 1989. Rapid redistribution of Golgi proteins into the endoplasmic reticulum in cells treated with Brefeldin A: evidence for membrane cycling from Golgi to ER. Cell. 56:801-813.
30. Martin, B.L., G. Schrader-Fischer, J. Busciglio, M. Duke, P. Paganetti, and B.A. Yankner. 1995. Intracellular accumulation of β-amyloid in cells expressing the Swedish mutant amyloid precursor proteins. J. Biol. Chem. 270:26727-26730.
31. Nordstedt, C., G. Caporaso, J. Thyberg, S. Gandy, and P. Greengard. 1993. Identification of the Alzheimer β/A4 amyloid precursor protein in clathrincoated vesicles purified from PC12 cells. J. Biol. Chem. 268:608-612.
32. Oltersdorf, T., P.J. Ward, T. Henriksson, E.C. Beattie, R. Neve, I. Lieberburg, and L.C. Fritz. 1990. The Alzheimer amyloid precursor protein. Identification of a stable intermediate in the biosynthetic/degradative pathway. J. Biol. Chem. 265:4492-4497.
33. Pelham, H.R. 1991. Multiple targets for Brefeldin A. Cell. 67:449-451.
34. Perez, R.G., S.L. Squazzo, and E.H. Koo. 1996. Enhanced release of amyloid β protein from codon-670/671 Swedish mutant β amyloid precursor protein occurs in both secretory and endocytic pathways. J. Biol. Chem. 271:9100-9107
35. Pleasure, S.J., and V.M.-Y. Lee. 1993. NTera 2 cells: a human cell line which displays characteristics expected of a human committed neuronal progenitor cell. J. Neurosci. Res. 35:585-602.
36. Pleasure, S.J., C. Page, and V.M.-Y. Lee. 1992. Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J. Neurosci. 12:1802-1815.
37. Ponte, P., P. Gonzalez-DeWhitt, J. Schilling, J. Miller, D. Hsu, B.D. Greenberg, K. Davis, W. Wallace, I. Lieberburg, F. Fuller, et al. 1988. A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature (Lond.). 331:525-527.
38. Saraste, J., G.E. Palade, and M.G. Farquhar. 1986. Temperature-sensitive steps in the transport of secretory proteins through the Golgi complex in exocrine pancreatic cells. Proc. Natl. Acad. Sci. USA. 83:6425-6429.
39. Saraste, J., and E. Kuismanen. 1984. Pre- and post-Golgi vacuoles operate in the transport of semliki forest virus membrane glycoproteins to the cell surface. Cell 38:535-549.
40. Scheuner, D., C. Eckman, M. Jensen, X. Song, M. Citron, N. Suzuki, T.D. Bird, J. Hardy, M. Hutton, W. Kukull, et al. 1996. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2:864-870.
41. Schweizer, A., J.A.M. Fransen, K. Matter, T.E. Kreis, L. Ginsel, and H.P. Hauri. 1990. Identification of an intermediate compartment involved in protein transport from endoplasmic reticulum to Golgi apparatus. Eur. J. Cell Biol. 53:185-196.
42. Selkoe, D.J. 1994. Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease. Annu. Rev. Cell Biol. 10:373-103.
43. Seubert, P., C. Vigo-Pelfrey, R. Esch, M. Lee, H. Dovey, D. Davis, S. Sinha, M. Schlossmacher, J. Whaley, C. Swindlehurst, et al. 1992. Isolation and quantitation of soluble Alzheimer's β-peptide from biological fluids. Nature (Lond.). 359:325-327.
44. Seubert, P., T. Oltersdorf, M.G. Lee, R. Barbour, C. Blomquist, D.L. Davis, K. Bryant, L.C. Fritz, D. Galasko, L.J. Thai, et al. 1993. Secretion of β-amyloid precursor protein cleaved at the amino terminus of the β-amyloid peptide. Nature (Lond.). 361:260-263.
45. Shoji, M., T.E. Golde, J. Ghiso, T.T. Cheung, S. Estus, L.M. Shaffer, X.-D. Cai, D.M. McKay, R. Tintner, B. Frangione, et al. 1992. Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science (Wash. DC). 258:126-129.
46. Sisodia, S.S. 1992. β-amyloid precursor protein cleavage by a novel membrane bound proteasc. Proc. Natl. Acad. Sci. USA. 89:6075-6079.
47. Sisodia, S.S., E.H. Koo, K. Beyreuther, A. Unterbeck, and D.L. Price. 1990. Evidence that β-amyloid protein in Alzheimer's disease is not derived by normal processing. Science (Wash. DC). 248:492-495.
48. St. George-Hyslop, P.M., R.E. Tanzi, R.J. Polinsky, J.L. Haines, L. Nee, P.C. Watkins, R.H. Myers, R.G. Feldman, D. Pollen, D. Drachman, et al. 1987. The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science (Wash. DC). 235:885-890.
49. Suzuki, N., A.C. Nairn, S.E. Gandy, and P. Greengard. 1992. Phosphorylation of Alzheimer amyloid precursor protein by protein kinase C. Neuroscience. 48:755-761.
50. Suzuki, N., T.T. Cheung, X.-D. Cai, A. Odaka, L. Otvos, Jr., C. Eckman, T.E. Golde, and S.G. Younkin. 1994. An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP717) mutants. Science (Wash. DC). 264:1336-1340.
51. Tanzi, R.E., A.I. McClatchey, E.D. Lamperti, L.L., Villa-Komaroff, J.F. Gusella, and R.L. Neve. 1988. Protease inhibitor domain encoded by an amyloid precursor mRNA associated with Alzheimer's disease. Nature (Lond.). 331:528-530.
52. Thinakaran, G., D.R. Borchelt, M.K. Lee, H.H. Slunt, L. Spitzer, G. Kim, F. Ratovitsky, F. Davenport, C. Nordstedt, M. Seeger, et al. 1996a. Endoproteolysis of Presenilin 1 and accumulation of processed derivatives in vivo. Neuron. 17:181-190.
53. Thinakaran, G., B.D. Teplow, R. Siman, B. Greenberg, and S.S. Sisodia. 1996b. Metabolism of the "Swedish" amyloid precursor protein variant in Neuro 2a (N2a) cells. J. Biol. Chem. 271:9390-9397.
54. 42 are generated intracellularly in cultured human neurons and their secretion increases with maturation. J. Biol. Chem. 271:8966-8970.
55. Weidemann, A., G. Konig, D. Bunke, P. Fischer, J.M. Salhaum, C. Masters, and K. Beyreuther. 1989. Identification, biogenesis, and localization of precursors of Alzheimer's Disease A4 Amyloid protein. Cell. 57:115-126.
56. Wertkin, A.M., R.S. Turner, S.J. Pleasure, T.E. Golde, S.G. Younkin, J.Q. Trojanowski, and V.M.-Y. Lee. 1993. Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular β-amyloid or A4 peptides. Proc. Natl. Acad. Sci. USA. 90:9513-9517.